SARAH MUCHAI: Open Payments
NPI 1760861918 · METHUEN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$811 in 11 payments from 7 companies in 2025. Trend: 2023 $412 · 2024 $386 · 2025 $811
Food & beverage: $811
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $295 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| Corcept Therapeutics | 1 | $116 |
| ACADIA Pharmaceuticals Inc | 1 | $101 |
| Otsuka America Pharmaceutical, Inc. | 1 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $63 |
| SCPHARMACEUTICALS INC. | 1 | $35 |
Products named: SPRAVATO, WAINUA, Korlym, NUPLAZID, REXULTI, CAPLYTA, FUROSCIX.
Industry payments across MA — which companies pay providers there.
